The global Generic Drugs Market is valued at USD 487.21 Billion in 2024 and is projected to reach a value of USD 898 Billion ...

Several new weight loss drugs are undergoing trials in the UK. These drugs will work similarly to those already available but ...

Pakistan’s national drug regulator has officially approved the marketing of a generic version of the potent antibiotic Daptomycin, made by a Chinese drug maker, in a move that could provide a new, ...

Biosimilar drugs are drugs that are a lot like biologics, but maybe not identical. Learn why this matters inside.

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Takeda, coming off a high of 2024 growth, is pushing through what it says will be the worst of its Vyvanse-related declines.

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to controversial practices around the sale of compounded drugs. These drugs are ...

Today, anthrax remains one of the deadliest and easiest biological weapons to produce. Yet 80 percent of the U.S. supply of ciprofloxacin is still imported. Moreover, most of those imports, whether ...

Viatris offers value with high free cash flow and dividends but faces growth challenges from legacy drug price erosion and ...

Medicare may cover Skyrizi (risankizumab-rzaa) if you have a plan with prescription drug benefits. Learn more.

Medicare may cover Ubrelvy (ubrogepant) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Ubrelvy is a brand-name drug that doctors may ...